Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership620 shares
Latest Disclosed Value $ 218,147
Pinnacle Bancorp, Inc. reports 11.91% increase in ownership of AMGN / Amgen Inc.

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 620 shares of Amgen Inc. (MX:AMGN) valued at $218,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 554 shares of Amgen Inc.. This represents a change in shares of 11.91% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Amgen Inc Com COM 031162100 620 66 11.91 218 20.44 0.0644
2026-01-22 2025-12-31 13F Amgen Inc Com COM 031162100 554 0 0.00 181 16.03 0.0531
2025-10-24 2025-09-30 13F Amgen Inc Com COM 031162100 554 -140 -20.17 156 -19.17 0.0462
2025-07-11 2025-06-30 13F Amgen Inc Com COM 031162100 694 -50 -6.72 194 -16.45 0.0598
2025-04-23 2025-03-31 13F Amgen Inc Com COM 031162100 744 7 0.95 232 20.31 0.0756
2025-01-14 2024-12-31 13F Amgen Inc Com COM 031162100 737 205 38.53 192 12.28 0.0625
2024-10-09 2024-09-30 13F Amgen Inc Com COM 031162100 532 -52 -8.90 171 -6.04 0.0458
2024-07-15 2024-06-30 13F Amgen Inc Com COM 031162100 584 91 18.46 182 30.00 0.0539
2024-04-16 2024-03-31 13F Amgen Inc Com COM 031162100 493 48 10.79 140 9.38 0.0415
2024-01-25 2023-12-31 13F Amgen Inc Com COM 031162100 445 0 0.00 128 7.56 0.0420
2023-10-18 2023-09-30 13F Amgen Inc Com COM 031162100 445 25 5.95 120 27.96 0.0425
2023-07-14 2023-06-30 13F Amgen Inc Com COM 031162100 420 -25 -5.62 93 -13.08 0.0319
2023-04-14 2023-03-31 13F Amgen Inc Com COM 031162100 445 0 0.00 108 0.0395
2023-01-24 2022-12-31 13F Amgen Inc Com COM 031162100 445 -12 -2.63 0 -100.00 0.0450
2022-10-25 2022-09-30 13F Amgen Inc Com COM 031162100 457 0 0.00 103 -7.21 0.0445
2022-07-12 2022-06-30 13F Amgen Inc Com COM 031162100 457 -15 -3.18 111 -2.63 0.0457
2022-04-14 2022-03-31 13F Amgen Inc Com COM 031162100 472 26 5.83 114 14.00 0.0396
2022-01-19 2021-12-31 13F Amgen Inc Com COM 031162100 446 74 19.89 100 26.58 0.0353
2021-10-12 2021-09-30 13F Amgen Inc Com COM 031162100 372 0 0.00 79 -13.19 0.0316
2021-07-15 2021-06-30 13F Amgen Inc Com COM 031162100 372 15 4.20 91 2.25 0.0415
2021-04-26 2021-03-31 13F Amgen Inc Com COM 031162100 357 0 0.00 89 8.54 0.0431
2021-01-13 2020-12-31 13F Amgen Inc Com COM 031162100 357 10 2.88 82 -6.82 0.0505
2020-10-13 2020-09-30 13F Amgen Inc Com COM 031162100 347 25 7.76 88 15.79 0.0620
2020-07-07 2020-06-30 13F Amgen Inc Com COM 031162100 322 0 0.00 76 16.92 0.0565
2020-04-09 2020-03-31 13F Amgen Inc Com COM 031162100 322 -29 -8.26 65 -23.53 0.0555
2020-01-10 2019-12-31 13F Amgen Inc Com COM 031162100 351 29 9.01 85 37.10 0.0589
2019-10-08 2019-09-30 13F Amgen Inc Com COM 031162100 322 0 0.00 62 5.08 0.0354
2019-07-08 2019-06-30 13F Amgen Inc Com COM 031162100 322 0 0.00 59 -3.28 0.0332
2019-04-05 2019-03-31 13F Amgen Inc Com COM 031162100 322 0 0.00 61 -3.17 0.0354
2019-03-20 2018-12-31 13F Amgen Inc Com COM 031162100 322 -205 -38.90 63 -26.74 0.0387
2017-04-17 2017-03-31 13F Amgen Inc Com COM 031162100 527 527 86 0.0608
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.